The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
NCI experience using yeast-brachyury vaccine (GI-6301) in patients (pts) with advanced chordoma.
Christopher Ryan Heery
No relevant relationships to disclose
Harpreet Singh
No relevant relationships to disclose
Jennifer L. Marte
No relevant relationships to disclose
Ravi Amrit Madan
No relevant relationships to disclose
Geraldine Helen O'Sullivan Coyne
No relevant relationships to disclose
Benedetto Farsaci
No relevant relationships to disclose
Timothy C. Rodell
Employment or Leadership Position - GlobeImmune
Stock Ownership - GlobeImmune
Research Funding - GlobeImmune
Other Remuneration - GlobeImmune
Claudia Palena
No relevant relationships to disclose
Jeffrey Schlom
Research Funding - GlobeImmune
James L. Gulley
No relevant relationships to disclose